Stock XVIVO XVIVO PERFUSION AB
Add to a list
To use this feature you must be a member
Log inSign up

All News Xvivo Perfusion AB

Equities

XVIVO

SE0004840718

Market Closed - Nasdaq Stockholm
Other stock markets
 12:00:00 2024-06-24 EDT 		5-day change 1st Jan Change
417 SEK -1.53% Intraday chart for Xvivo Perfusion AB -3.36% +26.56%
05-29 Nordic Stocks Dropped Wednesday; NEL Fell Furthest DJ
04-24 Nordic Shares Declined Wednesday; Svenska Handelsbnkn Ser A Fell Furthest DJ

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Nordic Stocks Dropped Wednesday; NEL Fell Furthest
DJ
Bulletin from Annual General Meeting in XVIVO Perfusion AB (publ)
AQ
Nordic Shares Declined Wednesday; Svenska Handelsbnkn Ser A Fell Furthest
DJ
Transcript : Xvivo Perfusion AB, Q1 2024 Earnings Call, Apr 24, 2024
Xvivo Perfusion AB Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Estimates compiled by Modular Finance on behalf of XVIVO Perfusion.
AQ
Xvivo Perfusion : Results from XVIVO's clinical trial NIHP2019 for heart preservation presented at ISHLT in Prague
PU
Results from XVIVO’s clinical trial NIHP2019 for heart preservation presented at ISHLT in Prague
AQ
Xvivo Perfusion AB Announces Results from Clinical Trial NIHP2019 for Heart Preservation Presented at ISHLT in Prague
CI
Xvivo Perfusion : Notice to AGM 2024
PU
Xvivo Perfusion : SORP 2024
PU
Xvivo Perfusion : Styrelsens 19-22 redogörelse (Eng)
PU
NOTICE TO ATTEND THE ANNUAL GENERAL MEETING IN XVIVO PERFUSION AB (PUBL)
AQ
Certain Shares of Xvivo Perfusion AB are subject to a Lock-Up Agreement Ending on 16-MAR-2024.
CI
The first-ever transplantation with a donor heart transported across the Atlantic Ocean – made possible by the use of XVIVO’s heart technology
AQ
Nordic Shares Moved Upward Thursday; Nokia Topped Leaders
DJ
Transcript : Xvivo Perfusion AB, 2023 Earnings Call, Jan 25, 2024
XVIVO presents Report on Operations 2023
AQ
Xvivo Perfusion AB Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Xvivo Perfusion AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. XVIVO Stock
  4. News Xvivo Perfusion AB